SCHEMBL25834235

SCHEMBL25834235

CCCC[N+](C)(C)CCOCCOCC[N+](C)(C)CCCO

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 6/20 0.50
HTT P42858 2/20 0.45
MEN1 O00255 1/20 0.45
THRB P10828 1/20 0.45
KMT2A Q03164 1/20 0.45
MAPT P10636 1/20 0.45
TSHR P16473 1/20 0.45
ALDH1A1 P00352 1/20 0.39
PRKD3 O94806 1/20 0.38
PRKCG P05129 1/20 0.38
PRKCB P05771 1/20 0.38
PRKCA P17252 1/20 0.38
PRKCH P24723 1/20 0.38
PRKCI P41743 1/20 0.38
PRKCE Q02156 1/20 0.38
PRKCQ Q04759 1/20 0.38
PRKCZ Q05513 1/20 0.38
PRKCD Q05655 1/20 0.38
PRKD1 Q15139 1/20 0.38
MLNR O43193 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25834237 0.98 DNM1 (0.52) DNM1HTTMEN1THRBKMT2A
SCHEMBL25834234 0.90 DNM1 (0.59) DNM1HTTMEN1THRBKMT2A
SCHEMBL29377128 0.89 DNM1 (0.57) DNM1HTTMEN1THRBKMT2A
SCHEMBL25834238 0.88 DNM1 (0.61) DNM1HTTMEN1THRBKMT2A
Iodide SCHEMBL8912350 0.87 DNM1 (0.55) DNM1HTTMEN1THRBKMT2A
Bromide SCHEMBL30630140 0.85 DNM1 (0.61) DNM1HTTKMT2AALDH1A1PRKD3
SCHEMBL17715356 0.85 DNM1 (0.65) DNM1HTTMEN1KMT2ATSHR
SCHEMBL17368709 0.83 DNM1 (0.54) DNM1HTTKMT2AALDH1A1MLNR
Bromide SCHEMBL9486958 0.83 DNM1 (0.67) DNM1HTTMEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL31490452 0.83 DNM1 (0.62) DNM1HTTMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218523-A1 Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218523-A1 Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents HACD3, C9, HACD2 DNM1 1502/4885HTT 657/4885MEN1 3082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.